Latest Period
Q4 2025
Security Snapshot
BriaCell Therapeutics Corp. - Common Stock, $0.01 par value (BCTX) Institutional Ownership
CUSIP: 107930208
13F Institutional Holders and Ownership History from Q1 2025 to Q4 2025
Institutions Reporting
0
Shares (Excl. Options)
0
Price
$0.69
- Type / Class
- Equity / Common Stock, $0.01 par value
- Symbol
- BCTX on Nasdaq
- Shares outstanding
- 4,043,321
- Price per share
- $0.69
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 0
- Total reported value
- $0
- Share change
- -66
- Value change
- -$48
- Number of holders
- 0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- BCTX - BriaCell Therapeutics Corp. - Common Stock, $0.01 par value is tracked under CUSIP 107930208.
- 0 institutions reported positions in Q4 2025.
- 4 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 1 to 0 between Q3 2025 and Q4 2025.
- Reported value moved from $48 to $0.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Official SEC Source
Backed by Form 13F
Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.
See Original FilingInvestment Quick Answers
What is CUSIP 107930208?
CUSIP 107930208 identifies BCTX - BriaCell Therapeutics Corp. - Common Stock, $0.01 par value in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Continue Investment Research
- Latest 13F filings for new institutional portfolio disclosures.
- Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
- Latest 10-Q/10-K reports to cross-check issuer fundamentals.
- Recent insider transactions for management buying/selling context.
- SEC investors directory and top value investors for manager-level discovery.
- All institutional ownership pages to compare adjacent CUSIP pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 107930208:
Significant Owners of BriaCell Therapeutics Corp. - Common Stock, $0.01 par value (BCTX) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Iroquois Capital Management, LLC | 9.1% | $4,736,000 | 1,600,000 | Richard Abbe | 15 Jul 2025 | |||
| CVI Investments, Inc. | 5.7% | +16% | $2,960,000 | +$1,906,577 | 1,000,000 | +181% | CVI Investments, Inc. | 15 Jul 2025 |
| ARMISTICE CAPITAL, LLC | 8.3% | $678,720 | 336,000 | Armistice Capital, LLC | 30 Jun 2025 | |||
| 3i, LP | 4.9% | -50% | $872,128 | -$821,582 | 190,006 | -49% | 3i, LP | 31 Mar 2025 |
As of 31 Dec 2025, 0 institutional investors reported holding 0 shares of BriaCell Therapeutics Corp. - Common Stock, $0.01 par value (BCTX). This represents 0% of the company’s total 4,043,321 outstanding shares.